336 related articles for article (PubMed ID: 28733131)
21. Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells.
Levasseur DN; Ryan TM; Pawlik KM; Townes TM
Blood; 2003 Dec; 102(13):4312-9. PubMed ID: 12933581
[TBL] [Abstract][Full Text] [Related]
22. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
23. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
24. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
[TBL] [Abstract][Full Text] [Related]
25. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.
Park SH; Lee CM; Dever DP; Davis TH; Camarena J; Srifa W; Zhang Y; Paikari A; Chang AK; Porteus MH; Sheehan VA; Bao G
Nucleic Acids Res; 2019 Sep; 47(15):7955-7972. PubMed ID: 31147717
[TBL] [Abstract][Full Text] [Related]
26. Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome.
Scaramuzza S; Biasco L; Ripamonti A; Castiello MC; Loperfido M; Draghici E; Hernandez RJ; Benedicenti F; Radrizzani M; Salomoni M; Ranzani M; Bartholomae CC; Vicenzi E; Finocchi A; Bredius R; Bosticardo M; Schmidt M; von Kalle C; Montini E; Biffi A; Roncarolo MG; Naldini L; Villa A; Aiuti A
Mol Ther; 2013 Jan; 21(1):175-84. PubMed ID: 22371846
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of using autologous transplantation to evaluate hematopoietic stem cell-based gene therapy strategies in transgenic mouse models of human disease.
Miller CL; Imren S; Antonchuk J; Kalberer C; Fabry ME; Nagel RL; Humphries RK; Eaves CJ
Mol Ther; 2002 Sep; 6(3):422-8. PubMed ID: 12231180
[TBL] [Abstract][Full Text] [Related]
28. Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols.
Larochelle A; Vormoor J; Lapidot T; Sher G; Furukawa T; Li Q; Shultz LD; Olivieri NF; Stamatoyannopoulos G; Dick JE
Hum Mol Genet; 1995 Feb; 4(2):163-72. PubMed ID: 7757063
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Testing of the Safety and Tolerability of Lentiviral Vector-Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies.
Visigalli I; Delai S; Ferro F; Cecere F; Vezzoli M; Sanvito F; Chanut F; Benedicenti F; Spinozzi G; Wynn R; Calabria A; Naldini L; Montini E; Cristofori P; Biffi A
Hum Gene Ther; 2016 Oct; 27(10):813-829. PubMed ID: 27431943
[TBL] [Abstract][Full Text] [Related]
30. Retroviral transduction of murine and human hematopoietic progenitors and stem cells.
Ciuculescu MF; Brendel C; Harris CE; Williams DA
Methods Mol Biol; 2014; 1185():287-309. PubMed ID: 25062637
[TBL] [Abstract][Full Text] [Related]
31. High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells.
Imren S; Fabry ME; Westerman KA; Pawliuk R; Tang P; Rosten PM; Nagel RL; Leboulch P; Eaves CJ; Humphries RK
J Clin Invest; 2004 Oct; 114(7):953-62. PubMed ID: 15467834
[TBL] [Abstract][Full Text] [Related]
32. Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.
Lagresle-Peyrou C; Lefrère F; Magrin E; Ribeil JA; Romano O; Weber L; Magnani A; Sadek H; Plantier C; Gabrion A; Ternaux B; Félix T; Couzin C; Stanislas A; Tréluyer JM; Lamhaut L; Joseph L; Delville M; Miccio A; André-Schmutz I; Cavazzana M
Haematologica; 2018 May; 103(5):778-786. PubMed ID: 29472357
[TBL] [Abstract][Full Text] [Related]
33. Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.
Zonari E; Desantis G; Petrillo C; Boccalatte FE; Lidonnici MR; Kajaste-Rudnitski A; Aiuti A; Ferrari G; Naldini L; Gentner B
Stem Cell Reports; 2017 Apr; 8(4):977-990. PubMed ID: 28330619
[TBL] [Abstract][Full Text] [Related]
34. Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.
Hoban MD; Cost GJ; Mendel MC; Romero Z; Kaufman ML; Joglekar AV; Ho M; Lumaquin D; Gray D; Lill GR; Cooper AR; Urbinati F; Senadheera S; Zhu A; Liu PQ; Paschon DE; Zhang L; Rebar EJ; Wilber A; Wang X; Gregory PD; Holmes MC; Reik A; Hollis RP; Kohn DB
Blood; 2015 Apr; 125(17):2597-604. PubMed ID: 25733580
[TBL] [Abstract][Full Text] [Related]
35. Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.
Stenger EO; Chinnadurai R; Yuan S; Garcia M; Arafat D; Gibson G; Krishnamurti L; Galipeau J
Biol Blood Marrow Transplant; 2017 May; 23(5):736-745. PubMed ID: 28132869
[TBL] [Abstract][Full Text] [Related]
36. A New Era for Hemoglobinopathies: More Than One Curative Option.
Psatha N; Papayanni PG; Yannaki E
Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
[TBL] [Abstract][Full Text] [Related]
37. Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype.
Brendel C; Guda S; Renella R; Bauer DE; Canver MC; Kim YJ; Heeney MM; Klatt D; Fogel J; Milsom MD; Orkin SH; Gregory RI; Williams DA
J Clin Invest; 2016 Oct; 126(10):3868-3878. PubMed ID: 27599293
[TBL] [Abstract][Full Text] [Related]
38. Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice.
Chen W; Wu X; Levasseur DN; Liu H; Lai L; Kappes JC; Townes TM
Stem Cells; 2000; 18(5):352-9. PubMed ID: 11007919
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral Infection of Mouse Bone Marrow Cells for Hematopoietic Stem Cell Transplantation.
Chen C; Guderyon MJ; Ge G; Clark RA; Li S
Methods Mol Biol; 2019; 1919():205-213. PubMed ID: 30656632
[TBL] [Abstract][Full Text] [Related]
40. Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates.
Walia JS; Neschadim A; Lopez-Perez O; Alayoubi A; Fan X; Carpentier S; Madden M; Lee CJ; Cheung F; Jaffray DA; Levade T; McCart JA; Medin JA
Hum Gene Ther; 2011 Jun; 22(6):679-87. PubMed ID: 21280983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]